ACB vs SURG
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 16, 2026
ACB
SURG
Investment Advisor Scores
SURG
AI Analyst Insights
Detailed Metrics Comparison
| Metric | ACB | SURG | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 109.8901 | 15.1515 | SURG |
| PEG Ratio | 0 | 0.5333 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -8.8% | 40.7% | SURG |
| Earnings Growth | -94.7% | -77.7% | SURG |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 38.0/100 | 50.1/100 | SURG |
| Profit Margin | -38.2% | -47.9% | ACB |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | AVOID NEW MONEY | HOLD | SURG |
Relative Price Performance (Last 90 Days)
Current Technical Phase
ACB
NeutralMixed signals - no dominant trend phase, RSI 49
SURG
MarkdownPrice below a falling SMA50 (slope -22.7%), weak momentum, RSI 35
Fundamentals Snapshot
| Metric | ACB | SURG |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -683.3 | 12.7 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.1% | 0.4% |
| Gross Margin | 0.4% | -0.2% |
| Operating Margin | -0.1% | 0.2% |
| EPS | -0.59 | -1.50 |
| Dividend Yield | — | — |